SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Bliss GVS Pharma’s arm incorporates wholly owned subsidiary

29 Jan 2022 Evaluate

Bliss GVS Pharma’s a wholly owned subsidiary -- Bliss GVS International PTE Singapore has incorporated a wholly owned subsidiary namely, Asterisk Lifesciences Democratic Republic of Congo (DRC).

The company's purpose are marketing, distribution & sale of pharmaceutical formulations at affordable prices for the local market; Sale of pharmaceutical and para pharmaceutical products, articles, equipment, supplies and materials of all kinds; Consignment and wholesale distribution of all imported pharmaceutical and para pharmaceutical articles, products and goods; Any operation of importation, purchase and storage of drugs and other health products with a view to their distribution directly to the various pharmacies and authorized health structures; and Importation, Selling and distribution of pharmaceutical formulations, APis, cosmetics, confectionary, food item, machineries, process equipments, healthcare services, diagnostics, medical equipments, pharmacy, warehousing, manufacturing of pharmaceutical formulations, packaging & repackaging of pharmaceutical, cosmetic and allied products. 

Bliss GVS Pharma is engaged in the manufacture of a wide range of Pessary Formulations, Suppository Formulations, Calcium Preparation, Protein Powders, Iron Preparation, Antibiotics, Analgesic & Antipyretics, Respiratory, Anti-inflammatory, Dermatological Preparations, Anti-Diarrhoeal products.

Bliss GVS Pharma Share Price

268.95 -4.80 (-1.75%)
23-Apr-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1679.85
Dr. Reddys Lab 1333.05
Cipla 1305.85
Zydus Lifesciences 947.10
Lupin 2340.20
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×